Pub. Date : 2018 Nov 1
PMID : 30121577
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. | 2,4-thiazolidinedione | peroxisome proliferator activated receptor gamma | Mus musculus |
2 | Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. | 2,4-thiazolidinedione | peroxisome proliferator activated receptor gamma | Mus musculus |
3 | Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. | 2,4-thiazolidinedione | peroxisome proliferator activated receptor gamma | Mus musculus |
4 | Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. | 2,4-thiazolidinedione | peroxisome proliferator activated receptor gamma | Mus musculus |
5 | Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a master regulator of adipogenesis and a target of the thiazolidinedione (TZD) class of antidiabetic drugs; therefore, identifying novel regulators of PPARgamma action in adipocytes is essential for the future development of therapeutics for diabetes. | 2,4-thiazolidinedione | peroxisome proliferator activated receptor gamma | Mus musculus |